Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Philippines’ Zuellig To Produce Generic Versions Of Own Branded Drugs

This article was originally published in PharmAsia News

Executive Summary

Zuellig Pharma Philippines plans to begin selling generic drugs as part of its product line that heretofore has been limited to branded products. The head of the Philippines unit of Zuellig Pharma said the firm intends to produce locally made branded generic versions of its branded drug. It plans to provide its formulations to Interphil Laboratories to produce the lower-cost versions. Kasigod Jamias said that with the generics lines, the company expected to duplicate its 5 percent to 10 percent growth recorded last year. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071603

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel